A detailed history of Lindbrook Capital, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 96 shares of BLFS stock, worth $2,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96
Previous 118 18.64%
Holding current value
$2,509
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$19.19 - $26.52 $422 - $583
-22 Reduced 18.64%
96 $2,000
Q2 2024

Jul 31, 2024

BUY
$15.14 - $22.99 $333 - $505
22 Added 22.92%
118 $2,000
Q4 2023

Jan 31, 2024

BUY
$8.99 - $16.86 $521 - $977
58 Added 152.63%
96 $1,000
Q3 2023

Oct 25, 2023

BUY
$10.81 - $22.96 $410 - $872
38 New
38 $0
Q1 2023

Apr 26, 2023

SELL
$17.67 - $26.07 $265 - $391
-15 Reduced 16.85%
74 $1,000
Q3 2022

Nov 10, 2022

BUY
$14.64 - $26.7 $790 - $1,441
54 Added 154.29%
89 $2,000
Q2 2022

Aug 01, 2022

BUY
$10.54 - $24.2 $274 - $629
26 Added 288.89%
35 $0
Q3 2020

Nov 03, 2020

BUY
$16.04 - $28.94 $144 - $260
9 New
9 $0

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.12B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.